Home / Publications / NDRC launches anti-trust investigation into pharmaceutical...

NDRC launches anti-trust investigation into pharmaceutical sector

08/06/2016

China’s top pricing-related anti-trust regulator, the National Development and Reform Commission (“NDRC”), has launched a new round of anti-trust investigations into pharmaceutical companies. A major US pharmaceutical company has been summoned for inquiry...

Read more

Authors

Portrait ofNick Beckett
Nick Beckett
Managing Partner
Beijing
Portrait ofVera Zhang
Vera Zhang
Senior Associate
Beijing
Portrait ofRoxie Meng
Roxie Meng
Senior Associate
Beijing